UPenn Treats First Cancer Patients in Crispr-Based Trial

(Bloomberg) -- Doctors at the University of Pennsylvania’s Abramson Cancer Center have infused two cancer patients with a Crispr-based medicine in another early human trial for the promising gene-e...